Bioequivalence of Intravenous Alteplase from Two Different Manufacturing Processes in Healthy Male Volunteers: Results from a Two-Stage, Adaptive-Design Study

OBJECTIVE: Alteplase is a recombinant tissue plasminogen activator used for thrombolytic treatment in several indications and is currently approved in Europe under the brand name Actilyse(®). The current manufacturing process for alteplase was recently modified to meet increasing global demands. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Glund, Stephan, Hoefler, Josef, Lang, Benjamin, Cafiero, Stephen, Panova-Noeva, Marina, Place, Corina, Wolff, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338556/
https://www.ncbi.nlm.nih.gov/pubmed/37248330
http://dx.doi.org/10.1007/s40262-023-01253-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338556/
https://www.ncbi.nlm.nih.gov/pubmed/37248330
http://dx.doi.org/10.1007/s40262-023-01253-3

Ejemplares similares